Beta
178669

THE EFFECT OF ADMINISTRATION OF ASCORBIC ACID IN PREVENTION OF CONTRAST INDUCED NEPHROPATHY IN PATIENTS WITH RENAL IMPAIRMENT UNDERGOING CORONARY INTERVENTION

Article

Last updated: 24 Dec 2024

Subjects

-

Tags

Cardiology

Abstract

ABSTRACT
Background: Contrast-induced nephropathy is a potentially avoidable complication caused during procedures involving the use of radiographic contrast media. All subjects, especially the high-risk ones, should be subjected to available preventive protocols prior to and after such procedures.
Objective: To evaluate the role of a hydration protocol involving the use of ascorbic acid plus the conventional sodium chloride hydration protocol N acetyl cysteine.
Patients and methods: The current study was conducted on 86 patients presenting to the Cardiology Department at National Heart Institute to undergo elective percutaneous coronary intervention (PCI) during the period from April 2011 to November 2011. The study population was divided into two equal groups: Group 1 received ascorbic acid prior and after the procedure and group 2 received the conventional hydration measures without ascorbic acid. Both groups received normal saline and NAC (N Acetyl Cysteine).
Results: There were no significant group differences regarding sex, incidence of diabetes mellitus, pre-existing renal impairment, age, hypertension, dyslipidemia, and the type and amount of contrast. Addition of ascorbic acid by hydration with normal saline and N- acetyle cysteine decreased significantly the rise in serum creatinine 48 hours (P=0.023) and 7 days (P=0.001) following coronary intervention. CIN occurred in one patient in ascorbic acid group versus 4 patients in the control group (P=0.36). Ascorbic acid did not show a significant effect regarding the protection against the contrast induced nephropathy versus the conventional hydration therapy.
Conclusion: Ascorbic acid did not show a significant effect regarding the protection against the contrast induced nephropathy versus the conventional hydration therapy.

DOI

10.21608/amj.2021.178669

Keywords

ascorbic acid, renal impairment, percutaneous coronary intervention, contrast-induced nephropathy

Authors

First Name

Amr

Last Name

Mohamed Imam Mohamed Amr

MiddleName

-

Affiliation

Department of Cardiology, Faculty of Medicine, Al-Azhar University

Email

dr.amrmohamed_imam@gmail.com

City

-

Orcid

-

First Name

Waleed

Last Name

Hassan Abd El-Hamied Asar

MiddleName

-

Affiliation

Department of Cardiology, Faculty of Medicine, Al-Azhar University

Email

-

City

-

Orcid

-

First Name

Mohamed

Last Name

Osama Fathy Kayed

MiddleName

-

Affiliation

Department of Cardiology, Faculty of Medicine, Al-Azhar University

Email

-

City

-

Orcid

-

First Name

Saad

Last Name

Ibrahim Dief Allah

MiddleName

-

Affiliation

Department of Cardiology, Faculty of Medicine, Al-Azhar University

Email

-

City

-

Orcid

-

First Name

Ali

Last Name

Ali Ramzy

MiddleName

-

Affiliation

Department of Cardiology, Faculty of Medicine, Al-Azhar University

Email

-

City

-

Orcid

-

Volume

50

Article Issue

3

Related Issue

25707

Issue Date

2021-07-01

Receive Date

2021-06-20

Publish Date

2021-07-01

Page Start

2,045

Page End

2,056

Print ISSN

1110-0400

Link

https://amj.journals.ekb.eg/article_178669.html

Detail API

https://amj.journals.ekb.eg/service?article_code=178669

Order

42

Type

Original Article

Type Code

941

Publication Type

Journal

Publication Title

Al-Azhar Medical Journal

Publication Link

https://amj.journals.ekb.eg/

MainTitle

THE EFFECT OF ADMINISTRATION OF ASCORBIC ACID IN PREVENTION OF CONTRAST INDUCED NEPHROPATHY IN PATIENTS WITH RENAL IMPAIRMENT UNDERGOING CORONARY INTERVENTION

Details

Type

Article

Created At

22 Jan 2023